Bristol-Myers Squibb CEO James Cornelius will retire. He will replaced by Lamberto Andreotti, Bristol announced...
The Food and Drug Administration has declined to approve a biotech drug for organ transplant...
The Food and Drug Administration has recommended approval for a biotech drug for treating kidney...
Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as...
Patent expiries on blockbuster branded drugs could mean huge profits for some retail pharmacy chains,...
A rare but serious liver disorder has been reported in some patients taking a drug...
A research firm for pharmaceutical and healthcare issues projected sales of more than $1 billion...
PricewaterhouseCoopers’ report that the personalized medicine market will grow 11% per year is just another...
Don’t be surprised to see an “Under New Management” sign hanging from the door of...